High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer.IE Smith, S. Ebbs, S. Johnston et al.|Journal of Clinical Oncology|1995Cited by 180
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IXStefan Aebi, Aron Goldhirsch, Zijie Sun et al.|Annals of Oncology|2011Cited by 55